Frontiers in drug safety and regulation最新文献

筛选
英文 中文
Promising treatment biomarkers in asthma 有希望治疗哮喘的生物标志物
Frontiers in drug safety and regulation Pub Date : 2023-11-07 DOI: 10.3389/fdsfr.2023.1291471
Barbara Bonnesen, Jens-Ulrik S. Jensen, Alexander G. Mathioudakis, Alexandru Corlateanu, Pradeesh Sivapalan
{"title":"Promising treatment biomarkers in asthma","authors":"Barbara Bonnesen, Jens-Ulrik S. Jensen, Alexander G. Mathioudakis, Alexandru Corlateanu, Pradeesh Sivapalan","doi":"10.3389/fdsfr.2023.1291471","DOIUrl":"https://doi.org/10.3389/fdsfr.2023.1291471","url":null,"abstract":"Asthma is a highly heterogenous disease which researchers over time have attempted to classify into different phenotypes and endotypes to improve diagnosis, prognosis and treatment. Earlier classifications based on reaction to environmental allergens, age, sex and lung function have evolved, and today, the use of precision medicine guided by biomarkers offers new perspectives on asthma management. Identifying biomarkers that may reveal the underlying pathophysiology of the disease will help to select the patients who will benefit most from specific treatments. This review explores the classification of asthma phenotypes and focuses on the most recent advances in using biomarkers to guide treatment.","PeriodicalId":489826,"journal":{"name":"Frontiers in drug safety and regulation","volume":"24 6","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135476648","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Identification of small cell lung cancer patients who are at risk of developing common serious adverse event groups with machine learning 用机器学习识别有发生常见严重不良事件风险的小细胞肺癌患者
Frontiers in drug safety and regulation Pub Date : 2023-09-15 DOI: 10.3389/fdsfr.2023.1267623
Linda Wanika, Neil D. Evans, Michael J. Chappell
{"title":"Identification of small cell lung cancer patients who are at risk of developing common serious adverse event groups with machine learning","authors":"Linda Wanika, Neil D. Evans, Michael J. Chappell","doi":"10.3389/fdsfr.2023.1267623","DOIUrl":"https://doi.org/10.3389/fdsfr.2023.1267623","url":null,"abstract":"Introduction: Across multiple studies, the most common serious adverse event groups that Small Cell Lung Cancer (SCLC) patients experience, whilst undergoing chemotherapy treatment, are: Blood and Lymphatic Disorders, Infections and Infestations together with Metabolism and Nutrition Disorders. The majority of the research that investigates the relationship between adverse events and SCLC patients, focuses on specific adverse events such as neutropenia and thrombocytopenia. Aim: This study aims to utilise machine learning in order to identify those patients who are at risk of developing common serious adverse event groups, as well as their specific adverse event classification grade. Methods: Data from five clinical trial studies were analysed and 12 analysis groups were formed based on the serious adverse event group and grade. Results: The best test runs for each of the models were able to produce an area under the curve (AUC) score of at least 0.714. The best model was the Blood and Lymphatic Disorder group, SAE grade 0 vs. grade 3 (best AUC = 1, sensitivity rate = 0.84, specificity rate = 0.96). Conclusion: The top features that contributed to this prediction were total bilirubin, alkaline phosphatase, and age. Future work should investigate the relationship between these features and common SAE groups.","PeriodicalId":489826,"journal":{"name":"Frontiers in drug safety and regulation","volume":"207 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135438634","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信